Rhythm Pharmaceuticals (RYTM) Cash from Financing Activities (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) posted Cash from Financing Activities of -$6.25 million for Q3 2026, compared with $189.3 million a year earlier.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Cash from Financing Activities (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Cash from Financing Activities at Rhythm Pharmaceuticals was -$15.76 million; for FY2025, it was $217.96 million, up 14.0% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 155.3% (FY2020 to FY2025).
- In prior years, Rhythm Pharmaceuticals' Cash from Financing Activities was $191.24 million in FY2024 (+157.2%), $74.37 million in FY2023 (-65.2%), $213.83 million in FY2022 (+28.4%) and $166.48 million in FY2021.
- The Q3 2026 figure stands as the lowest quarterly Cash from Financing Activities in data going back to Q1 2017.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was -$1.17 million (Q2 2026), -$5.4 million (Q1 2026) and -$2.95 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Rhythm Pharmaceuticals | 7.90 Bn | 6.52 Bn | 79.96 Mn | -6.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -6.25 Mn |
| Jun 30, 2026 | -1.17 Mn |
| Mar 31, 2026 | -5.40 Mn |
| Dec 31, 2025 | -2.95 Mn |
| Sep 30, 2025 | 189.30 Mn |
| Jun 30, 2025 | -889,000.00 |
| Mar 31, 2025 | 32.50 Mn |
| Dec 31, 2024 | 38.33 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | 146.18 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 2.42 Mn |
| Sep 30, 2023 | 73.04 Mn |
| Jun 30, 2023 | -965,000.00 |
| Mar 31, 2023 | -133,000.00 |
| Dec 31, 2022 | 17.37 Mn |
| Sep 30, 2022 | 158.56 Mn |
| Jun 30, 2022 | 37.50 Mn |
| Mar 31, 2022 | 399,000.00 |
| Dec 31, 2021 | 100,000.00 |
API Access
Rhythm Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();